Worth reading
44Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
6900
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance and allocation of share acquisition rights as compensation (stock options)
Who receives how much
6,900 common shares of the company (69 share acquisition rights, 100 shares per right)
3 directors (excluding directors serving as Audit and Supervisory Committee members)4,300 shares
3 directors serving as Audit & Supervisory Committee members2,600 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
No monetary payment is required in exchange for the share acquisition rights.
Terms of the stock acquisition rights
Exercise price
¥1 per share. No adjustment provisions were stated.
Exercise period
Start Date 29 October 2026 / End date 28 October 2056
Number of Stock Acquisition Rights
Total number issued 69 / Unexercised balance Not disclosed
Reason for acquisition without consideration
If a proposal for a merger, company split, share exchange, share transfer, amendment to the articles of incorporation concerning restrictions on share transfers, or similar transaction is approved at a general meeting of shareholders, or, where a shareholder resolution is not required, a board resolution is adopted, the share acquisition rights may be acquired without consideration on a date separately determined by the company's board of directors.
Categories and Number of Persons Covered
Category Directors (excluding directors who are Audit and Supervisory Committee members) / Number of Employees 3 directors (including 2 outside directors) / Number allocated 43 (4,300 shares), Category Directors serving as Audit and Supervisory Committee members / Number of Employees 3 directors (including 2 outside directors) / Number allocated 26 (2,600 shares)
Intended allottee's holding policy
Board approval is required for the transfer of the share acquisition rights.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance and allocation of share acquisition rights as compensation (stock options) |
| Number of shares to be issued or disposed of | 6,900 common shares of the company (69 share acquisition rights, 100 shares per right) |
| Issue price and disposal price | No monetary payment is required in exchange for the share acquisition rights. |
| Intended allottee | Category 3 directors (excluding directors serving as Audit and Supervisory Committee members) / Number of stock acquisition rights 43 / Number of underlying shares 4,300 shares, Category 3 directors serving as Audit & Supervisory Committee members / Number of stock acquisition rights 26 / Number of underlying shares 2,600 shares |
| Intended allottee's holding policy | Board approval is required for the transfer of the share acquisition rights. |
| Exercise price | ¥1 per share. No adjustment provisions were stated. |
| Exercise period | Start Date 29 October 2026 / End date 28 October 2056 |
| Number of Stock Acquisition Rights | Total number issued 69 / Unexercised balance Not disclosed |
| Reason for acquisition without consideration | If a proposal for a merger, company split, share exchange, share transfer, amendment to the articles of incorporation concerning restrictions on share transfers, or similar transaction is approved at a general meeting of shareholders, or, where a shareholder resolution is not required, a board resolution is adopted, the share acquisition rights may be acquired without consideration on a date separately determined by the company's board of directors. |
| Categories and Number of Persons Covered | Category Directors (excluding directors who are Audit and Supervisory Committee members) / Number of Employees 3 directors (including 2 outside directors) / Number allocated 43 (4,300 shares), Category Directors serving as Audit and Supervisory Committee members / Number of Employees 3 directors (including 2 outside directors) / Number allocated 26 (2,600 shares) |
Items this document does not state (18)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To link the value of the share acquisition rights to the share price and align the interests and potential benefits and detriments of directors and shareholders by reflecting the improvement of medium- to long-term corporate value and shareholder value in directors' compensation. The company also aims to increase directors' motivation and morale to contribute to improving medium- to long-term performance and corporate value, and to raise awareness of appropriate auditing.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.